Oblique Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Oblique Therapeutics's estimated annual revenue is currently $5.6M per year.
- Oblique Therapeutics's estimated revenue per employee is $312,667
Employee Data
- Oblique Therapeutics has 18 Employees.
- Oblique Therapeutics grew their employee count by -22% last year.
Oblique Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $14.9M | 70 | 6% | N/A | N/A |
#2 | $45.6M | 210 | 6% | N/A | N/A |
#3 | $21.3M | 102 | 7% | N/A | N/A |
#4 | $78.6M | 354 | 10% | N/A | N/A |
#5 | $1200M | 1267 | -6% | $2.4B | N/A |
#6 | $5.6M | 18 | -22% | N/A | N/A |
#7 | $8.2M | 37 | 9% | N/A | N/A |
#8 | $26.5M | 117 | 7% | N/A | N/A |
What Is Oblique Therapeutics?
Oblique Therapeutics is a privately held Swedish biotech, developing innovative new medicines for severe diseases with a large unmet medical need focusing on pain, and aggressive metastatic cancer. The company uses Abiprot an in house- invented next-generation antibody platform that can generate antibodies with programmed function against the full human proteome.. We make medicines that matter to patients.
keywords:N/A
N/A
Total Funding
18
Number of Employees
$5.6M
Revenue (est)
-22%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Oblique Therapeutics News
2022-03-30 - Lumakras Drug Market Share Analysis 2022 Growth, Size Estimates, Global
Revenues, Industry Trends & Upcoming
... Mirati Therapeutics Inc., Moderna Inc., Oblique Therapeutics AB, ... popularity of advanced therapies, are fuelling the market growth.
Other Companies in Göteborg
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.8M | 18 | 13% | N/A |
#2 | $1.2M | 18 | 13% | N/A |
#3 | $2.9M | 18 | -5% | $565.1M |
#4 | $1.7M | 19 | 36% | N/A |
#5 | $2.1M | 19 | -5% | N/A |